Static - PET/CT scan

DIAGNOSTIC_TEST3 trials

Sponsors

GE Healthcare

Conditions

Breast CancerHealthy VolunteersMalignant Solid TumorOncology

Phase 1

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

RecruitingNCT05629689

GE HealthcareMalignant Solid Tumor, Oncology

Start: 2023-01-27End: 2029-03-10Target: 50Updated: 2025-11-17

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

WithdrawnNCT05634954

GE HealthcareBreast Cancer

Start: 2026-02-28End: 2026-12-31Updated: 2025-10-23

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

CompletedNCT06398730

GE HealthcareHealthy Volunteers

Start: 2024-07-02End: 2026-02-23Updated: 2026-03-06